Divyalatha S Warrier
Overview
Explore the profile of Divyalatha S Warrier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borhade P, LeBoa C, Jayaprasad N, Date K, Haldar P, Harvey P, et al.
Am J Trop Med Hyg
. 2024 Sep;
111(5):1060-1065.
PMID: 39348826
In 2018, the Navi Mumbai Municipal Corporation implemented phase 1 of a public sector typhoid conjugate vaccine campaign in Navi Mumbai, India, targeting all children aged 9 months to 14...
2.
Date K, LeBoa C, Hoffman S, Haldar P, Harvey P, An Q, et al.
Am J Trop Med Hyg
. 2024 Aug;
111(4):848-852.
PMID: 39137766
Typbar-TCV®, a typhoid conjugate vaccine (TCV), was prequalified by the World Health Organization in 2017. We evaluated its effectiveness in a mass vaccination program targeting children 9 months to 14...
3.
Da Silva K, Date K, Hirani N, LeBoa C, Jayaprasad N, Borhade P, et al.
mBio
. 2023 Jul;
14(4):e0117923.
PMID: 37504577
We performed whole-genome sequencing of 174 Typhi and 54 Paratyphi A isolates collected through prospective surveillance in the context of a phased typhoid conjugate vaccine introduction in Navi Mumbai, India....
4.
Hoffman S, LeBoa C, Date K, Haldar P, Harvey P, Shimpi R, et al.
Clin Infect Dis
. 2023 Mar;
77(1):138-144.
PMID: 36947143
Background: The World Health Organization recommends vaccines for prevention and control of typhoid fever, especially where antimicrobial-resistant typhoid circulates. In 2018, the Navi Mumbai Municipal Corporation (NMMC) implemented a typhoid...